Sino Biological newly launched a panel of research reagents fo... - 07 December 2021 22:04

BEIJING, China, Dec. 7, 2021 /PRNewswire-AsiaNet/ -- Sino Biological, Inc. (http://www.sinobiological.com; SHE: 301047) announced today that it has launched a panel of research reagents for the newly identified Omicron variant (B.1.1.529) of the SARS-COV-2 virus, which quickly raised concerns around...

  QUOMI Launches An Innovative, Premium, Digital, Community Netw... - 07 December 2021 12:20

DORTMUND, Germany, Dec. 7, 2021 /PRNewswire-AsiaNet/-- QUOMI [ https://quomi.com/signup/ ] as a premium, digital, healthcare community aims at bringing a new order and possibilities for all levels of HCP by disrupting old structures and setting new standards. We have created a platform that is extr...

  Ho Ho (Oh No!) 2021's Hardest Holiday Conversation: Covid Test... - 07 December 2021 11:22

SYDNEY, Dec. 7, 2021 /PRNewswire-AsiaNet/ -- According to new research from Rapid Test and Trace Australia ( https://c212.net/c/link/?t=0&l=en&o=3380963-1&h=523026671&u=https%3A%2F%2Frapidtestsaustralia.com%2F&a=Rapid+Test+%26+Trace+Australia ), only 42.6% of Australians plan to ask family a...

  Gan and Lee Pharmaceuticals Announces U.S. FDA Clearance of In... - 07 December 2021 06:56

BEIJING and BRIDGEWATER, N.J., Dec. 6, 2021 /PRNewswire-AsiaNet/ -- Gan and Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan and Lee, stock code: 603087.SH), is pleased to announce that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for the compa...

  Moscow ranked first among European cities in the ranking of in... - 07 December 2021 01:52

MOSCOW, Dec, 6. 2021 /PRNewswire-AsiaNet/ -- Moscow ranks third in the world, behind New York and San Francisco Moscow is recognized as the first European city in the ranking of innovations, that are used for the formation of resilience to the coronavirus. It is ahead of London and Barcel...

  RedHill Biopharma Reports that Opaganib Mechanism Not Impacted... - 06 December 2021 23:45

TEL AVIV, Israel and RALEIGH, N.C., December 6, 2021, /PRNewswire-AsiaNet/-- Unique Mode of Action Opaganib works by targeting the human host cell rather than the virus itself and is therefore not expected to be impacted by spike protein mutations, providing a strong rationale for its potential to address the Omicron SA...

  Donisi Health Named 2021's "Future Unicorn" by E&T Magazine - 06 December 2021 23:02

TEL AVIV, Israel, December 6, 2021 /PRNewswire-AsiaNet/-- MedTech Startup Focused on Home Monitoring for Patients with Congestive Heart Failure and Other Chronic Diseases Receives the "Future Unicorn" Innovation Award from E&T E&T Magazine, the official publication of the Institution of Engineering a...

  Decode Genetics Publishes the Largest Ever Study of the Plasma... - 03 December 2021 04:35

REYKJAVIK, Iceland, Dec. 2, 2021 /PRNewswire-AsiaNet/ -- In a study published today in Nature genetics, scientists at deCODE genetics , a subsidiary of the pharmaceutical company Amgen, demonstrate how measuring the levels of a large number of proteins in plasma at population scale when combined with da...

  GenScript and BioComo Join Forces to Accelerate Novel Intranas... - 01 December 2021 16:21

TOKYO and SINGAPORE, Dec. 1, 2021 /PRNewswire-AsiaNet/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a leading global biotechnology company, and BioComo Incorporation, a drug discovery venture based in Mie prefecture, Japan, today announces a strategic agreement for joint research ...

  Silexon Partners with Excelra, Deploying GOSTAR to Strengthen ... - 01 December 2021 11:32

HYDERABAD, India and NANJING, China, Dec. 1, 2021 /PRNewswire-AsiaNet/ -- Excelra, a leading global data & analytics provider, today announced its partnership with Silexon AI Technology, a next-generation biotech company with a scalable AI/ML (Artificial Intelligence and Machine Learning) platform for drug discovery...